Stool Softener plus Stimulant Laxative 50 mg/1
Docusate Sodium and Sennosides · TABLET, FILM COATED · Meijer, Inc.
Stool Softener plus Stimulant Laxative is a tablet, film coated containing docusate sodium and sennosides at 50 mg/1, taken oral. Manufactured by Meijer, Inc..
Key Facts
- Brand Name
- Stool Softener plus Stimulant Laxative
- Generic Name
- Docusate Sodium and Sennosides
- NDC Code (Product)
79481-0304- Manufacturer
- Meijer, Inc.
- Strength
- 50 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- 505G(a)(3)
- Marketing Start
- 03/01/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is Stool Softener plus Stimulant Laxative used for?
Stool Softener plus Stimulant Laxative contains Docusate Sodium and Sennosides. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Stool Softener plus Stimulant Laxative a controlled substance?
Stool Softener plus Stimulant Laxative is not classified as a controlled substance by the DEA.
What is the generic name for Stool Softener plus Stimulant Laxative?
The generic name for Stool Softener plus Stimulant Laxative is Docusate Sodium and Sennosides. There are 11 other brand versions of Docusate Sodium and Sennosides.
What is the NDC code for Stool Softener plus Stimulant Laxative 50 mg/1?
The NDC (National Drug Code) for Stool Softener plus Stimulant Laxative 50 mg/1 is 79481-0304, listed by Meijer, Inc..
Other Docusate Brands
See all →- Stool Softener Laxative50 mg/163941-878
- Stool Softener Laxative Plus Stimulant50 mg/10363-0827
- STOOL SOFTENER AND STIMULANT LAXATIVE50 mg/111673-209
- Stool Softener Plus Stimulant Laxative50 mg/121130-829
- Stool Softener Laxative50 mg/136800-555
- Laxative Docusate Sodium with Senna50 mg/136800-861
- Stool Softener Laxative50 mg/146122-669
- Laxacin50 mg/150488-0901
- Stool Softener with Stimulant Laxative50 mg/159726-855
- Stool Softener Stimulant laxative50 mg/163868-875
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)